Novartis Ag (NVS) Free Cash Flow (2009 - 2026)
Novartis Ag's Free Cash Flow came in at $5.56 billion for Q2 2026, down 12.2% from $6.33 billion a year earlier but up 38.3% from the prior quarter.
Novartis Ag (NVS) Free Cash Flow (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Free Cash Flow of $19.38 billion, down 10.2% year-over-year; for FY2025, it was $17.6 billion, up 8.3% from FY2024.
- Free Cash Flow has increased in each of the last three years, with a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- Going back by year, Free Cash Flow was $16.25 billion in FY2024 (+21.3%), $13.4 billion in FY2023 (+0.6%), $13.32 billion in FY2022 (-4.9%) and $14.01 billion in FY2021 (+13.2%).
- The five-year range for quarterly Free Cash Flow is $1.91 billion (Q1 2022) to $6.93 billion (Q3 2025).
- Year-over-year, Free Cash Flow increased in six of the last eight quarters, with growth averaging 16.0%.
- The fastest year-over-year change in Free Cash Flow over five years came in Q1 2023 (growth of 64.0%), and the weakest in Q4 2025 (a decline of 39.5%).
- Business Quant data shows NVS's Free Cash Flow at $4.02 billion (Q1 2026), $2.87 billion (Q4 2025) and $6.93 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 8.22 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 6.36 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Vertex Pharmaceuticals | 141.76 Bn | 113.76 Bn | 2.84 Bn | 1.01 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.56 Bn |
| Mar 31, 2026 | 4.02 Bn |
| Dec 31, 2025 | 2.87 Bn |
| Sep 30, 2025 | 6.93 Bn |
| Jun 30, 2025 | 6.33 Bn |
| Mar 31, 2025 | 3.90 Bn |
| Dec 31, 2024 | 4.75 Bn |
| Sep 30, 2024 | 6.61 Bn |
| Jun 30, 2024 | 4.62 Bn |
| Mar 31, 2024 | 2.49 Bn |
| Dec 31, 2023 | 2.95 Bn |
| Sep 30, 2023 | 5.64 Bn |
| Jun 30, 2023 | 3.35 Bn |
| Mar 31, 2023 | 3.13 Bn |
| Dec 31, 2022 | 4.42 Bn |
| Sep 30, 2022 | 4.94 Bn |
| Jun 30, 2022 | 3.50 Bn |
| Mar 31, 2022 | 1.91 Bn |
| Dec 31, 2021 | 4.34 Bn |
| Sep 30, 2021 | 5.28 Bn |
Novartis Ag Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();